National Healthcare Properties Inc. Class A Common Stock (NHP)

FairStock Score: 16/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

As a value investor, I start with the business and the balance sheet, not the story. National Healthcare Properties is a small, self-managed REIT, market cap $440.7M at the 2026-10-13 close and $15.51 per share, owning healthcare real estate with an emphasis on senior housing. Because it is a REIT, EPS and P/E are distorted by depreciation; the proper FFO/AFFO figures are not in my data, so I lean on price-to-book, leverage, revenue trend, and dividend yield. The record is troubled. In fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $87.5M and net income was -$5.4M, or diluted EPS -$0.13. In fiscal Q2 2025, revenue was $85.3M and net income was -$20.8M, so revenue edged up and the loss narrowed. For FY2025, revenue was $342.3M and net income was -$57.7M; for FY2024, revenue was $353.8M and net income was -$190.3M. Losses are shrinking, but FairStock notes losses in each of the last four years, so earning power is unproven. Financial health is mixed. TTM free cash flow is $23.8M, a 5.4% FCF yield, and the dividend yield is 1.88%. But debt-to-equity is 0.81, ROCE is 1.19%, Altman Z-score is -0.87, and Piotroski is 4/9. FairStock Score is 16/100. At 1.07 times book, the price does not demand perfection, but without FFO/AFFO and better returns on capital, I cannot call this a high-quality bargain.

In plain English: National Healthcare Properties owns healthcare real estate, mostly senior housing. The business has been losing money, though recent losses are smaller than a year ago. At the 2026-10-13 close, the shares trade near the value of the company's net assets, so the price looks roughly fair rather than clearly cheap or expensive based on the data given.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer